(CIDRAP News) An interim report from a major study of the US's only licensed anthrax vaccine suggests it may be possible to reduce local side effects without sacrificing effectiveness by changing the injection route and using fewer doses.
(CIDRAP News) – Federal health officials yesterday announced a plan to supply mail carriers with antibiotics so they will be protected and prepared to deliver the drugs to others in case of an anthrax attack.
The program will start with a $500,000 pilot project involving carriers in Minneapolis and St. Paul, which were chosen because of their extensive bioterrorism preparations, according to an Associated Press (AP) report yesterday.
(CIDRAP News) – Emergent BioSolutions announced today that it has received a $29.7 million contract from the federal government to continue work on another of its next-generation anthrax vaccine candidates.
(CIDRAP News) Two organizations recently reported winning US government contracts for research on drugs that could work against multiple bioterror-related diseases such as plague, tularemia, and anthrax.
(CIDRAP News) Sen. Patrick Leahy, chairman of the Senate Judiciary Committee and a target of the 2001 anthrax attacks, said this week that he disbelieves the FBI's conclusion that Dr. Bruce E. Ivins was the sole perpetrator of the attacks, according to news services.
(CIDRAP News) The FBI plans to ask the National Academy of Sciences to review the bureau's investigation that led to its conclusion that government microbiologist Bruce E. Ivins committed the 2001 anthrax attacks, FBI Director Robert Mueller III told Congress today.
(CIDRAP News) Cross-contamination of clinical specimens in two Idaho hospital laboratories that were conducting proficiency tests triggered brief concern about a potential anthrax attack in 2006, underscoring the value of proper lab practices, according to a report from the Centers for Disease Control and Prevention (CDC).
(CIDRAP News) – Members of Congress plan to press the FBI for more information about its investigation of the 2001 anthrax attacks at hearings scheduled Sep 16 and 17, amid persistent doubts in some quarters about the bureau's conclusion that the late microbiologist Dr. Bruce Ivins was the culprit.
(CIDRAP News) – Emergent BioSolutions Inc. recently announced that it won a federal contract worth $24.3 million to develop a monoclonal antibody treatment to block the effects of anthrax toxin.
(CIDRAP News) US Navy and Air Force officials recently reported a suspension of work in their biodefense laboratories to allow a thorough review of safety procedures, following the Army's announcement in early August that it would review security measures at the lab that housed the work of the late Bruce E. Ivins, whom federal officials believe played a role in the 2001 anthrax attacks.
